Muscle Invasive Urothelial Carcinoma
Advertisement
Researchers evaluated the data of 50 specimens from patients who underwent TURBT and cystectomy for UC.
The new recommendations included changes to neoadjuvant and adjuvant chemotherapy and radical cystectomy.
Results from the NIAGARA trial show significant survival benefits with durvalumab for muscle invasive bladder cancer.
WGS-based ctDNA detection offered a median lead time of 131 days over radiographic imaging.
Dr. Calvo offers insights on an interim analysis of the atezobladderpreserve phase 2 clinical trial in MIBC.
Drs. Cigliola and Nizam discuss the implications of the reported SURE-01/02 study interim results.
Of the 26 patients with pathological assessment upon safety visit, all reached pCR, while none received cystectomy.
Neoadjuvant SG shows promising clinical activity in patients with MIBC and may help avoid radical cystectomy.
Disitamab vedotin, a novel anti-HER2 antibody-drug conjugate, was paired with toripalimab, an anti–PD-1 monoclonal ...
For patients with organ-confined urothelial carcinoma of urinary bladder, trimodal therapy is recommended.
New findings from the Nure-Combo trial examined the use of ABX with nivolumab followed by RC and adjuvant nivolumab.
RT to recurrence sites may not have an effect on oncologic outcomes in patients with MIBC after RC.
Identifying tumor biomarkers associated with pCR to neoadjuvant pembro or NAC prior to cystectomy in patients with MIBC.
Dr. Galsky shares the first OS data update on the CheckMate 274 trial, which he gave at the 2024 EAU Congress.
Signatera quantifies cancer and the time of any recurrence events to assist in identifying treatment options.
Researchers analyzed the effects of NAC on complete and overall response as well as cancer-specific survival after RT.
Patients received 68Ga-FAP-2286 PET, and investigators recorded the SUVmax of 68Ga-FAP-2286 PET-positive lesions.
Data from 458 patients who underwent RC between October 2005 and October 2020 and 146 in the PURE-01 trial was analyzed.
Dr. Geynisman highlights the CheckMate 274 study into long-term survival following treatment with adjuvant nivolumab.
Tanya Jindal discusses the safety and efficacy of neoadjuvant atezolizumab prior to radical cystectomy for MIBC.
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2024 Mashup Media, LLC. All rights reserved.